

Her surgeon, Kim Burchiel, M.D., professor of neurological surgery in the OHSU School of Medicine, is accustomed to pioneering advancements in health care. Known as NRTX-1001 neuronal cell therapy, the surgeon injects high-purity inhibitory neurons - derived from human stem cells - into the brain. The procedure involves injecting inhibitory nerve cells, called interneurons, into a precisely defined focal point in the brain to quell seizures. Previously, she endured about 14 seizures a month with no relief from medication.

“I’m able to do things without being concerned that a seizure is going to happen while I’m out and about. 26 at Oregon Health & Science University. As one of the first two participants in the country to undergo a new type of brain cell therapy procedure to treat an intractable form of epilepsy, the 59-year-old Portlander has been almost seizure-free since she underwent the experimental procedure on Oct. (OHSU/Christine Torres Hicks)Īnnette Adkins doesn’t think of herself as a medical trailblazer. Known as NRTX-1001 neuronal cell therapy, the technique has been tried in two patients nationwide so far as part of an ongoing multisite clinical trial.

26 implanting inhibitory nerve cells into a precisely defined focal point in the brain to quell seizures. Annette Adkins, walking in her Portland neighborhood, has been nearly seizure-free since undergoing an experimental procedure at OHSU on Oct.
